BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19262119)

  • 1. Phenylboronic acid selectively inhibits human prostate and breast cancer cell migration and decreases viability.
    Bradke TM; Hall C; Carper SW; Plopper GE
    Cell Adh Migr; 2008; 2(3):153-60. PubMed ID: 19262119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenylboronic acid is a more potent inhibitor than boric acid of key signaling networks involved in cancer cell migration.
    McAuley EM; Bradke TA; Plopper GE
    Cell Adh Migr; 2011; 5(5):382-6. PubMed ID: 21975546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the enzymatic activity of prostate-specific antigen by boric acid and 3-nitrophenyl boronic acid.
    Gallardo-Williams MT; Maronpot RR; Wine RN; Brunssen SH; Chapin RE
    Prostate; 2003 Jan; 54(1):44-9. PubMed ID: 12481254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular changes in boric acid-treated DU-145 prostate cancer cells.
    Barranco WT; Eckhert CD
    Br J Cancer; 2006 Mar; 94(6):884-90. PubMed ID: 16495920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of silibinin on the viability, migration and adhesion of the human prostate adenocarcinoma (PC-3) cell line.
    Mokhtari MJ; Motamed N; Shokrgozar MA
    Cell Biol Int; 2008 Aug; 32(8):888-92. PubMed ID: 18538589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boric acid inhibits human prostate cancer cell proliferation.
    Barranco WT; Eckhert CD
    Cancer Lett; 2004 Dec; 216(1):21-9. PubMed ID: 15500945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic and additive effects of modified citrus pectin with two polybotanical compounds, in the suppression of invasive behavior of human breast and prostate cancer cells.
    Jiang J; Eliaz I; Sliva D
    Integr Cancer Ther; 2013 Mar; 12(2):145-52. PubMed ID: 22532035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inositol hexaphosphate (IP6) inhibits key events of cancer metastasis: I. In vitro studies of adhesion, migration and invasion of MDA-MB 231 human breast cancer cells.
    Tantivejkul K; Vucenik I; Shamsuddin AM
    Anticancer Res; 2003; 23(5A):3671-9. PubMed ID: 14666663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel and selective inhibitor of PKC ζ potently inhibits human breast cancer metastasis in vitro and in mice.
    Wu J; Liu S; Fan Z; Zhang L; Tian Y; Yang R
    Tumour Biol; 2016 Jun; 37(6):8391-401. PubMed ID: 26733166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troglitazone inhibits cell migration, adhesion, and spreading by modulating cytoskeletal rearrangement in human breast cancer cells.
    Wang PS; Chou FS; Porchia L; Saji M; Pinzone JJ
    Mol Carcinog; 2008 Dec; 47(12):905-15. PubMed ID: 18314876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of the metastatic progression of breast cancer with an organometallic ruthenium compound.
    Bergamo A; Masi A; Dyson PJ; Sava G
    Int J Oncol; 2008 Dec; 33(6):1281-9. PubMed ID: 19020762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1,25-Dihydroxyvitamin D3 decreases human prostate cancer cell adhesion and migration.
    Sung V; Feldman D
    Mol Cell Endocrinol; 2000 Jun; 164(1-2):133-43. PubMed ID: 11026565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesion and migration of extracellular matrix-stimulated breast cancer.
    Bartsch JE; Staren ED; Appert HE
    J Surg Res; 2003 Mar; 110(1):287-94. PubMed ID: 12697413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Zinc inhibits magnesium-dependent migration of human breast cancer MDA-MB-231 cells on fibronectin.
    Lymburner S; McLeod S; Purtzki M; Roskelley C; Xu Z
    J Nutr Biochem; 2013 Jun; 24(6):1034-40. PubMed ID: 23026493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amygdalin Modulates Prostate Cancer Cell Adhesion and Migration In Vitro.
    Mani J; Neuschäfer J; Resch C; Rutz J; Maxeiner S; Roos F; Chun FK; Juengel E; Blaheta RA
    Nutr Cancer; 2020; 72(3):528-537. PubMed ID: 31298931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of thiolated glycosaminoglycans on the behavior of breast cancer cells: toward the development of in vitro models of cancer.
    Köwitsch A; Chhalotre A; Groth T
    Int J Artif Organs; 2017 Mar; 40(1):31-39. PubMed ID: 28222208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of local anesthetics on breast cancer cell viability and migration.
    Li R; Xiao C; Liu H; Huang Y; Dilger JP; Lin J
    BMC Cancer; 2018 Jun; 18(1):666. PubMed ID: 29914426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New curcumin analogues exhibit enhanced growth-suppressive activity and inhibit AKT and signal transducer and activator of transcription 3 phosphorylation in breast and prostate cancer cells.
    Lin L; Hutzen B; Ball S; Foust E; Sobo M; Deangelis S; Pandit B; Friedman L; Li C; Li PK; Fuchs J; Lin J
    Cancer Sci; 2009 Sep; 100(9):1719-27. PubMed ID: 19558577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pomegranate juice and specific components inhibit cell and molecular processes critical for metastasis of breast cancer.
    Rocha A; Wang L; Penichet M; Martins-Green M
    Breast Cancer Res Treat; 2012 Dec; 136(3):647-58. PubMed ID: 23065001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frondoside A inhibits human breast cancer cell survival, migration, invasion and the growth of breast tumor xenografts.
    Al Marzouqi N; Iratni R; Nemmar A; Arafat K; Ahmed Al Sultan M; Yasin J; Collin P; Mester J; Adrian TE; Attoub S
    Eur J Pharmacol; 2011 Oct; 668(1-2):25-34. PubMed ID: 21741966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.